A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2018
At a glance
- Drugs Abemaciclib (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Eli Lilly
- 20 Mar 2018 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
- 20 Mar 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Sep 2018.
- 08 Aug 2017 Status changed from not yet recruiting to recruiting.